18.02
price down icon1.48%   -0.27
after-market Handel nachbörslich: 18.08 0.06 +0.33%
loading

Finanzdaten der Scilex Holding Company-Aktie (SCLX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
66.42%
5.004
14.90 14.44 16.37 10.88
Cost Of Revenue
70.50%
1.384
4.691 3.768 4.39 3.84
Gross Profit
64.54%
3.62
10.21 10.67 11.98 7.044
Operating Expenses
18.32%
31.52
38.59 30.59 27.60 26.52
Benefits Costs and Expenses
45.52%
31.08
21.36 18.82 53.95 35.26
Costs And Expenses
45.52%
31.08
21.36 18.82 53.95 35.26
Operating Income/Loss
1.69%
-27.90
-28.38 -19.92 -15.62 -19.48
Nonoperating Income/Loss
91.71%
1.818
21.92 15.53 - -
Income/Loss From Continuing Operations Before Tax
303.65%
-26.08
-6.461 -4.388 -37.58 -24.38
Income/Loss From Continuing Operations After Tax
303.72%
-26.08
-6.46 -4.388 -37.58 -24.38
Net Income/Loss
303.72%
-26.08
-6.46 -4.388 -37.58 -24.38
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
99.99%
0.0116
131.02 0.127 0.1202 0.1024
Diluted Average Shares
99.99%
0.0116
133.96 0.127 0.1202 0.1024
Basic Earnings Per Share
-2.26
- -0.03 -0.31 -0.24
Diluted Earnings Per Share
4,420%
-2.26
-0.05 -0.03 -0.31 -0.24
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
drug_manufacturers_general SNY
$50.30
price up icon 0.34%
drug_manufacturers_general PFE
$24.92
price down icon 0.88%
$114.75
price up icon 0.53%
$289.58
price up icon 0.38%
drug_manufacturers_general NVO
$55.34
price down icon 1.74%
drug_manufacturers_general MRK
$84.99
price down icon 0.40%
Kapitalisierung:     |  Volumen (24h):